Regulation of myocardial oxygen delivery in response to graded reductions in hematocrit

role of K+ channels

Alexander M. Kiel, Adam G. Goodwill, Jillian N. Noblet, April L. Barnard, Daniel J. Sassoon, Johnathan Tune

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

This study was designed to identify mechanisms responsible for coronary vasodilation in response to progressive decreases in hematocrit. Isovolemic hemodilution was produced in open-chest, anesthetized swine via concurrent removal of 500 ml of arterial blood and the addition of 500 ml of 37 °C saline or synthetic plasma expander (Hespan, 6% hetastarch in 0.9% sodium chloride). Progressive hemodilution with Hespan resulted in an increase in coronary flow from 0.39 ± 0.05 to 1.63 ± 0.16 ml/min/g (P < 0.001) as hematocrit was reduced from 32 ± 1 to 10 ± 1% (P < 0.001). Overall, coronary flow corresponded with the level of myocardial oxygen consumption, was dependent on arterial pressures ≥ ~ 60 mmHg, and occurred with little/no change in coronary venous PO2. Anemic coronary vasodilation was unaffected by the inhibition of nitric oxide synthase (l-NAME: 25 mg/kg iv; P = 0.92) or voltage-dependent K+ (KV) channels (4-aminopyridine: 0.3 mg/kg iv; P = 0.52). However, administration of the KATP channel antagonist (glibenclamide: 3.6 mg/kg iv) resulted in an ~ 40% decrease in coronary blood flow (P < 0.001) as hematocrit was reduced to ~ 10%. These reductions in coronary blood flow corresponded with significant reductions in myocardial oxygen delivery at baseline and throughout isovolemic anemia (P < 0.001). These data indicate that vasodilator factors produced in response to isovolemic hemodilution converge on vascular smooth muscle glibenclamide-sensitive (KATP) channels to maintain myocardial oxygen delivery and that this response is not dependent on endothelial-derived nitric oxide production or pathways that mediate dilation via KV channels.

Original languageEnglish (US)
Article number65
JournalBasic Research in Cardiology
Volume112
Issue number6
DOIs
StatePublished - Nov 1 2017

Fingerprint

Hydroxyethyl Starch Derivatives
Hemodilution
Hematocrit
KATP Channels
Glyburide
Oxygen
Vasodilation
4-Aminopyridine
Vasodilator Agents
Vascular Smooth Muscle
Sodium Chloride
Oxygen Consumption
Nitric Oxide Synthase
Anemia
Dilatation
Arterial Pressure
Nitric Oxide
Swine
Thorax

Keywords

  • Anemia
  • Coronary
  • K channels
  • K channels
  • Nitric oxide
  • Swine

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Regulation of myocardial oxygen delivery in response to graded reductions in hematocrit : role of K+ channels. / Kiel, Alexander M.; Goodwill, Adam G.; Noblet, Jillian N.; Barnard, April L.; Sassoon, Daniel J.; Tune, Johnathan.

In: Basic Research in Cardiology, Vol. 112, No. 6, 65, 01.11.2017.

Research output: Contribution to journalArticle

Kiel, Alexander M. ; Goodwill, Adam G. ; Noblet, Jillian N. ; Barnard, April L. ; Sassoon, Daniel J. ; Tune, Johnathan. / Regulation of myocardial oxygen delivery in response to graded reductions in hematocrit : role of K+ channels. In: Basic Research in Cardiology. 2017 ; Vol. 112, No. 6.
@article{303f81b9d9ec4371b9f3092d59674ba0,
title = "Regulation of myocardial oxygen delivery in response to graded reductions in hematocrit: role of K+ channels",
abstract = "This study was designed to identify mechanisms responsible for coronary vasodilation in response to progressive decreases in hematocrit. Isovolemic hemodilution was produced in open-chest, anesthetized swine via concurrent removal of 500 ml of arterial blood and the addition of 500 ml of 37 °C saline or synthetic plasma expander (Hespan, 6{\%} hetastarch in 0.9{\%} sodium chloride). Progressive hemodilution with Hespan resulted in an increase in coronary flow from 0.39 ± 0.05 to 1.63 ± 0.16 ml/min/g (P < 0.001) as hematocrit was reduced from 32 ± 1 to 10 ± 1{\%} (P < 0.001). Overall, coronary flow corresponded with the level of myocardial oxygen consumption, was dependent on arterial pressures ≥ ~ 60 mmHg, and occurred with little/no change in coronary venous PO2. Anemic coronary vasodilation was unaffected by the inhibition of nitric oxide synthase (l-NAME: 25 mg/kg iv; P = 0.92) or voltage-dependent K+ (KV) channels (4-aminopyridine: 0.3 mg/kg iv; P = 0.52). However, administration of the KATP channel antagonist (glibenclamide: 3.6 mg/kg iv) resulted in an ~ 40{\%} decrease in coronary blood flow (P < 0.001) as hematocrit was reduced to ~ 10{\%}. These reductions in coronary blood flow corresponded with significant reductions in myocardial oxygen delivery at baseline and throughout isovolemic anemia (P < 0.001). These data indicate that vasodilator factors produced in response to isovolemic hemodilution converge on vascular smooth muscle glibenclamide-sensitive (KATP) channels to maintain myocardial oxygen delivery and that this response is not dependent on endothelial-derived nitric oxide production or pathways that mediate dilation via KV channels.",
keywords = "Anemia, Coronary, K channels, K channels, Nitric oxide, Swine",
author = "Kiel, {Alexander M.} and Goodwill, {Adam G.} and Noblet, {Jillian N.} and Barnard, {April L.} and Sassoon, {Daniel J.} and Johnathan Tune",
year = "2017",
month = "11",
day = "1",
doi = "10.1007/s00395-017-0654-x",
language = "English (US)",
volume = "112",
journal = "Basic Research in Cardiology",
issn = "0300-8428",
publisher = "D. Steinkopff-Verlag",
number = "6",

}

TY - JOUR

T1 - Regulation of myocardial oxygen delivery in response to graded reductions in hematocrit

T2 - role of K+ channels

AU - Kiel, Alexander M.

AU - Goodwill, Adam G.

AU - Noblet, Jillian N.

AU - Barnard, April L.

AU - Sassoon, Daniel J.

AU - Tune, Johnathan

PY - 2017/11/1

Y1 - 2017/11/1

N2 - This study was designed to identify mechanisms responsible for coronary vasodilation in response to progressive decreases in hematocrit. Isovolemic hemodilution was produced in open-chest, anesthetized swine via concurrent removal of 500 ml of arterial blood and the addition of 500 ml of 37 °C saline or synthetic plasma expander (Hespan, 6% hetastarch in 0.9% sodium chloride). Progressive hemodilution with Hespan resulted in an increase in coronary flow from 0.39 ± 0.05 to 1.63 ± 0.16 ml/min/g (P < 0.001) as hematocrit was reduced from 32 ± 1 to 10 ± 1% (P < 0.001). Overall, coronary flow corresponded with the level of myocardial oxygen consumption, was dependent on arterial pressures ≥ ~ 60 mmHg, and occurred with little/no change in coronary venous PO2. Anemic coronary vasodilation was unaffected by the inhibition of nitric oxide synthase (l-NAME: 25 mg/kg iv; P = 0.92) or voltage-dependent K+ (KV) channels (4-aminopyridine: 0.3 mg/kg iv; P = 0.52). However, administration of the KATP channel antagonist (glibenclamide: 3.6 mg/kg iv) resulted in an ~ 40% decrease in coronary blood flow (P < 0.001) as hematocrit was reduced to ~ 10%. These reductions in coronary blood flow corresponded with significant reductions in myocardial oxygen delivery at baseline and throughout isovolemic anemia (P < 0.001). These data indicate that vasodilator factors produced in response to isovolemic hemodilution converge on vascular smooth muscle glibenclamide-sensitive (KATP) channels to maintain myocardial oxygen delivery and that this response is not dependent on endothelial-derived nitric oxide production or pathways that mediate dilation via KV channels.

AB - This study was designed to identify mechanisms responsible for coronary vasodilation in response to progressive decreases in hematocrit. Isovolemic hemodilution was produced in open-chest, anesthetized swine via concurrent removal of 500 ml of arterial blood and the addition of 500 ml of 37 °C saline or synthetic plasma expander (Hespan, 6% hetastarch in 0.9% sodium chloride). Progressive hemodilution with Hespan resulted in an increase in coronary flow from 0.39 ± 0.05 to 1.63 ± 0.16 ml/min/g (P < 0.001) as hematocrit was reduced from 32 ± 1 to 10 ± 1% (P < 0.001). Overall, coronary flow corresponded with the level of myocardial oxygen consumption, was dependent on arterial pressures ≥ ~ 60 mmHg, and occurred with little/no change in coronary venous PO2. Anemic coronary vasodilation was unaffected by the inhibition of nitric oxide synthase (l-NAME: 25 mg/kg iv; P = 0.92) or voltage-dependent K+ (KV) channels (4-aminopyridine: 0.3 mg/kg iv; P = 0.52). However, administration of the KATP channel antagonist (glibenclamide: 3.6 mg/kg iv) resulted in an ~ 40% decrease in coronary blood flow (P < 0.001) as hematocrit was reduced to ~ 10%. These reductions in coronary blood flow corresponded with significant reductions in myocardial oxygen delivery at baseline and throughout isovolemic anemia (P < 0.001). These data indicate that vasodilator factors produced in response to isovolemic hemodilution converge on vascular smooth muscle glibenclamide-sensitive (KATP) channels to maintain myocardial oxygen delivery and that this response is not dependent on endothelial-derived nitric oxide production or pathways that mediate dilation via KV channels.

KW - Anemia

KW - Coronary

KW - K channels

KW - K channels

KW - Nitric oxide

KW - Swine

UR - http://www.scopus.com/inward/record.url?scp=85030236592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030236592&partnerID=8YFLogxK

U2 - 10.1007/s00395-017-0654-x

DO - 10.1007/s00395-017-0654-x

M3 - Article

VL - 112

JO - Basic Research in Cardiology

JF - Basic Research in Cardiology

SN - 0300-8428

IS - 6

M1 - 65

ER -